Every Heartbeat Counts: Take Action & Make an Impact This World Heart Day

How prepared is your country to tackle the rising burden of Cardiovascular Disease (CVD) in Asia Pacific (APAC)?   The cost of CVD in APAC CVD is the number 1 cause of death in APAC.   6 in 10 global...

The effectiveness of telemonitoring and integrated personalised diabetes management in people with insulin-treated type 2 diabetes mellitus

Chinese expert consensus on the risk assessment and management of panvascular disease in patients with type 2 diabetes mellitus (2022 edition)

STRONG-HF: Enhancing GDMT regimen in Asia

Implementation of STRONG-HF protocol in heart failure management: an Australian perspective

Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China

Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients

Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers 

STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure

Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring

Heart Failure Management in India – Overcoming Present Challenges

STRONG-HF study highlighting benefits of treatment optimisation

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Uncovering the Cardio-renal Risks of Chinese T2DM patients: Back to the Future with CUHK!

Management of Diabetes in Japan – Can Patients Play a More Significant Role?

T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP

ESC 2021 Heart Failure Guidelines: What’s new?

Heart Failure in Hong Kong- Present Challenges and Future Strategies

Rapid Algorithms for Faster Triage of ED Patients with Suspected AMI – What Are We Waiting For?

Digital Prediction Platforms: A catalyst towards personalized CVD prognosis

CVD Management in T2DM – JCS and JDS Joint Consensus

ESC Recommendation: High sensitivity troponin assay vs conventional assay

ESC Recommendation: Rapid algorithms using hs troponin in ED

How to Implement ESC Rapid Algorithm Successfully?

The Changes in Rapid Algorithms for Acute Coronary Syndrome

Factors affecting high-sensitivity cardiac troponin (hs-cTn) levels

DAPA-HF and EMPEROR-Reduced Study Highlights

The role of biomarkers in HF

Digital health in HF management

Summary of APSC High Sensitivity Troponin T Consensus

APSC hs-TnT Consensus & Future Use of Biomarker in T2DM & COVID-19

Management of Cardiovascular Risks of COVID-19 Patients

COVID-19 and the Heart, Experience from Front Line

2800+ Healthcare Professionals have cardiac insights delivered to their inbox
Sign up to receive the latest updates via your email
Keep me informed